Filana Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| FLNA | FBLG | SER | QNTM | GANX | FULC | |
|---|---|---|---|---|---|---|
| Market cap | 27.63M | 6.86M | 42.93M | 14.21M | 48.44M | 287.96M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.3 | -1.6 | -0.3 | -1.6 | -6.9 |
| Price/book | 0.4 | 1.3 | 2.3 | 2.1 | 4.3 | 0.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −80.74% | −85.54% | −58.98% | −74.27% | −41.58% | −50.72% |
| Today | −3.75% | −2.17% | −7.65% | 0.00% | −3.48% | +0.80% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All FLNA news ›Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
Findings provide new insight into simufilam’s effects on cellular stress responses and mitochondrial function New research demonstrates a 37% reduction in elevated ATF4, consistent with attenuation of the ATF4-associated cellular stress…
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
Planned Phase 2a Trial Design The study is designed to assess safety, tolerability, pharmacokinetics, and seizure-related measures, including seizure frequency, seizure intensity and duration, nighttime seizures, and sleep-related…
Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam
Filana Therapeutics (FLNA) announced that the U.S. Food and Drug Administration, FDA, has lifted the clinical hold on the Company’s investigatio... Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam Filana…
Filana Therapeutics, Inc. Announces Resignation of Michael O'Donnell from the Board, Effective At Conclusion of 2026 Annual Meeting of Stockholders
Filana Therapeutics, Inc. announced that on April 22, 2026, Michael O'Donnell notified the Board of Directors of his decision to resign from the Board, effective at the conclusion of the Company's... Published on 04/28/2026 at 04:01 pm EDT…
Cassava Sciences Changing Name to Filana Therapeutics
Cassava Sciences said Tuesday it is changing its name to Filana Therapeutics and ticker to FLNA. Filana Therapeutics will start trading on Nasdaq on Wednesday, according to the company. Shares of... Biotechnology & Medical Research Cassava…
Filana Therapeutics, Inc.: Total Return chart (Dividends reinvested) - Nasdaq stock market
See the history of Filana Therapeutics, Inc., with dividends reinvested. (Total Return chart) FLNA Stock market Total Return chart Filana Therapeutics, Inc. Biotechnology & Medical Research Past dividends on Filana Therapeutics, Inc. All…
Fifth Circuit Vacates Class Certification in Filana Therapeutics Securities Case
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends. Fifth Circuit Vacates Class Certification in Filana Therapeutics…
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
2026 Maxim Growth Summit Conference Details: Date: October 12-14, 2026 Location: The Hard Rock Hotel NYC Filana Therapeutics, Inc. (NASDAQ: FLNA), is a biotechnology company focused on developing novel, investigational therapies to…
Filana Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Filana Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time FLNA price, Nasdaq stock exchange Relative Strength Chart Filana Therapeutics, Inc. Biotechnology & Medical Research All financial…
Filana Therapeutics, Inc. will Change its Ticker to FLNA from SAVA
Effective March 11, 2026, Filana Therapeutics, Inc. will change its Nasdaq Capital Market stock ticker symbol to FLNA from SAVA.... Published on 03/11/2026 at 06:20 am EDT Effective March 11, 2026, Filana Therapeutics, Inc. will change its…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com6
- markets.businessinsider.com2
- clinicaltrialvanguard.com1
- globenewswire.com1
- manilatimes.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.